Applied Dna Sciences Inc (BNBX)

$2.76 +0.01 (0.36%)
Market Cap 12.41M
Revenue (ttm) 3.43M
Net Income (ttm) -6.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -203.79%
Debt to Equity Ratio 0.00
Volume 48,512
Avg Vol 1,681,914
Day's Range N/A - N/A
Shares Out 4.36M
Stochastic %K 10%
Beta 0.15
Analysts Hold
Price Target N/A

Company Profile

BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic...

Industry: Asset Management
Sector: Financial Services
Phone: 631 240 8800
Fax: 631 240 8900
Website: www.bnbx.io
Address:
50 Health Sciences Drive, Stony Brook, United States
boomshiva
boomshiva Jan. 13 at 3:02 PM
$BNBX Looking back to last week, would have been a good return buying at 1.15 - 1.20 and selling here. Quick and easy 33%. I didn't dare.
1 · Reply
avxone
avxone Jan. 13 at 12:44 PM
$BNBX looks all retail jump ship here nothing left for anyone to get excited about
0 · Reply
avxone
avxone Jan. 13 at 1:22 AM
$BNBX anyone have any idea what’s going on?
0 · Reply
avxone
avxone Jan. 12 at 11:17 PM
$BNBX scumbags
0 · Reply
avxone
avxone Jan. 12 at 1:30 PM
$BNBX scammmoney
0 · Reply
Bazzzigar
Bazzzigar Jan. 10 at 3:22 PM
$BNBX buy the dip in ASST
0 · Reply
Alchemy_Trader
Alchemy_Trader Jan. 8 at 7:01 PM
$BNBX after this purchase, the company was sitting on $16.7 million in BNB coin. The market cap is sitting at $6.77 million. Undervalued just on that aspect, which doesn't take into account their other business aspects. $PAPL
1 · Reply
InvincibleX
InvincibleX Jan. 8 at 12:35 AM
$BNBX who is a global manufacturer of in vitro diagnostics (IVDs) ?
1 · Reply
avxone
avxone Jan. 7 at 1:12 PM
$BNBX another day another shit price action
0 · Reply
avxone
avxone Jan. 6 at 12:35 PM
$BNBX looks every retail holder exited this scam but me
1 · Reply
Latest News on BNBX
BNB Plus Corp. (BNBX) Receives $1.2M Accelerated LineaDNA™ Order

Jan 5, 2026, 8:01 AM EST - 9 days ago

BNB Plus Corp. (BNBX) Receives $1.2M Accelerated LineaDNA™ Order

BNB Plus Corp. (BNBX) Announces Largest Ever Shipment of LineaDNATM

Dec 18, 2025, 8:00 AM EST - 27 days ago

BNB Plus Corp. (BNBX) Announces Largest Ever Shipment of LineaDNATM

BNB Plus Provides BNB Treasury and Operational Updates

Dec 9, 2025, 8:00 AM EST - 5 weeks ago

BNB Plus Provides BNB Treasury and Operational Updates

Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board

Nov 17, 2025, 8:00 AM EST - 2 months ago

Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board

BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update

Oct 28, 2025, 8:00 AM EDT - 2 months ago

BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update

Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million

Oct 22, 2025, 8:00 AM EDT - 3 months ago

Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million

Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX' Reflecting Digital Asset Treasury Strategy

Oct 6, 2025, 8:00 AM EDT - 3 months ago

Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX' Reflecting Digital Asset Treasury Strategy

Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation

Sep 29, 2025, 3:08 PM EDT - 3 months ago

Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences

Sep 23, 2025, 8:30 AM EDT - 4 months ago

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

Aug 14, 2025, 4:10 PM EDT - 5 months ago

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

Jul 24, 2025, 9:00 AM EDT - 6 months ago

Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

Jul 7, 2025, 9:00 AM EDT - 6 months ago

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

Jun 30, 2025, 9:00 AM EDT - 7 months ago

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

Jun 17, 2025, 4:10 PM EDT - 7 months ago

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

Jun 16, 2025, 9:00 AM EDT - 7 months ago

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

May 29, 2025, 8:00 AM EDT - 8 months ago

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

May 15, 2025, 4:05 PM EDT - 8 months ago

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

May 14, 2025, 11:30 AM EDT - 8 months ago

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

Apr 21, 2025, 9:00 AM EDT - 9 months ago

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Apr 8, 2025, 9:00 AM EDT - 10 months ago

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

Apr 1, 2025, 9:45 AM EDT - 10 months ago

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

Mar 26, 2025, 9:00 AM EDT - 10 months ago

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

Mar 12, 2025, 8:00 AM EDT - 11 months ago

Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript

Feb 14, 2025, 2:10 PM EST - 11 months ago

Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript

Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

Feb 13, 2025, 4:03 PM EST - 11 months ago

Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

Feb 12, 2025, 12:00 PM EST - 1 year ago

Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14

Feb 11, 2025, 8:30 AM EST - 1 year ago

Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

Jan 10, 2025, 9:00 AM EST - 1 year ago

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

Jan 8, 2025, 4:30 PM EST - 1 year ago

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

Dec 18, 2024, 9:00 AM EST - 1 year ago

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

Dec 17, 2024, 4:05 PM EST - 1 year ago

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

Dec 16, 2024, 10:00 AM EST - 1 year ago

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 30, 2024, 7:15 AM EDT - 1 year ago

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Oct 15, 2024, 10:30 AM EDT - 1 year ago

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit

Sep 17, 2024, 9:15 AM EDT - 1 year ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

Sep 17, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

Applied DNA Launches Mpox Clade I and Clade II Testing Service

Sep 11, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Launches Mpox Clade I and Clade II Testing Service

Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan

Sep 4, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan

Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?

Aug 23, 2024, 1:19 PM EDT - 1 year ago

Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

Aug 23, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

Aug 19, 2024, 3:25 PM EDT - 1 year ago

Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

Applied DNA Sciences, Inc. (APDN) Q3 2024 Earnings Call Transcript

Aug 11, 2024, 12:29 PM EDT - 1 year ago

Applied DNA Sciences, Inc. (APDN) Q3 2024 Earnings Call Transcript

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

Jul 29, 2024, 11:57 AM EDT - 1 year ago

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

Jul 29, 2024, 11:10 AM EDT - 1 year ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract

Jul 18, 2024, 10:00 AM EDT - 1 year ago

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

Jun 20, 2024, 9:15 AM EDT - 1 year ago

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

MRVI

Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing

Jun 18, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing

boomshiva
boomshiva Jan. 13 at 3:02 PM
$BNBX Looking back to last week, would have been a good return buying at 1.15 - 1.20 and selling here. Quick and easy 33%. I didn't dare.
1 · Reply
avxone
avxone Jan. 13 at 12:44 PM
$BNBX looks all retail jump ship here nothing left for anyone to get excited about
0 · Reply
avxone
avxone Jan. 13 at 1:22 AM
$BNBX anyone have any idea what’s going on?
0 · Reply
avxone
avxone Jan. 12 at 11:17 PM
$BNBX scumbags
0 · Reply
avxone
avxone Jan. 12 at 1:30 PM
$BNBX scammmoney
0 · Reply
Bazzzigar
Bazzzigar Jan. 10 at 3:22 PM
$BNBX buy the dip in ASST
0 · Reply
Alchemy_Trader
Alchemy_Trader Jan. 8 at 7:01 PM
$BNBX after this purchase, the company was sitting on $16.7 million in BNB coin. The market cap is sitting at $6.77 million. Undervalued just on that aspect, which doesn't take into account their other business aspects. $PAPL
1 · Reply
InvincibleX
InvincibleX Jan. 8 at 12:35 AM
$BNBX who is a global manufacturer of in vitro diagnostics (IVDs) ?
1 · Reply
avxone
avxone Jan. 7 at 1:12 PM
$BNBX another day another shit price action
0 · Reply
avxone
avxone Jan. 6 at 12:35 PM
$BNBX looks every retail holder exited this scam but me
1 · Reply
avxone
avxone Jan. 6 at 12:35 PM
$BNBX piece of shit scam
0 · Reply
avxone
avxone Jan. 6 at 3:13 AM
$BNBX how did this close red with news!? Scam and rigged
0 · Reply
avxone
avxone Jan. 6 at 1:44 AM
$BNBX I don’t even know how they short this stock
0 · Reply
avxone
avxone Jan. 6 at 1:43 AM
$BNBX I watch trash all Rip but this epic trash bleeds no Matter what
0 · Reply
avxone
avxone Jan. 5 at 7:37 PM
$BNBX retail doesn’t even own this and penny stock flippers dont find this interesting as well. Don’t know what’s will increase share price or a squeeze
0 · Reply
avxone
avxone Jan. 5 at 5:52 PM
$BNBX should have ripped to 3.30 at minimum on this news
0 · Reply
avxone
avxone Jan. 5 at 4:21 PM
$BNBX so Fuckin pathetic
0 · Reply
avxone
avxone Jan. 5 at 1:36 PM
$BNBX literally trash that doesn’t move even on good news! Penny stock that sucks ass
0 · Reply
avxone
avxone Jan. 5 at 1:29 PM
$BNBX maybe 4 million shares exchanged on Friday is setting up for a rip on this news but still no follow through
0 · Reply
avxone
avxone Jan. 5 at 1:27 PM
$BNBX still no rip this should be 5 bucks today
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Jan. 5 at 1:25 PM
$BNBX
0 · Reply
avxone
avxone Jan. 5 at 1:21 PM
$BNBX it has potential but I don’t trust anyone here
0 · Reply